Hermann Einsele

Corimmun GmbH operates as a biotechnology company which engages in the development of drugs. It specializes in peptides and biological drugs with focus on inflammatory mechanisms in heart failure and atherosclerosis. The company was founded by Martin Ungerer, Dorothea Siegel-Axel, Roland Jahns, Paul Gawaz Meinrad, Martin Lohse, and Götz Münch in 2006 and is headquartered in Neuss, Germany.

advanceCOR GmbH operates as a clinical drug developing company. The firm provides ELISA-based assay development on a fee-for-service basis, e. g. for the detection of drugs or other agents or for antibody detection in blood samples or other liquids. The company was founded by Roland Jahns, Dorothea Siegel-Axel, Martin Ungerer, Götz Münch, Martin Lohse, Roland Jahns, and Meinrad Paul Gawaz in June 2012 and is headquartered in Martinsried, Germany.

Helmholtz-Zentrum für Infektionsforschung GmbH provides bio-medical research and development services. The firm engages in research projects focused on infection biology and its clinical application and practical implementation. It also specializes in the examination of pathogens that are either medically relevant or that can be used as models for the research of infections. Its research topics encompass bacterial and viral pathogens, immune response, and anti-infectives. The company was founded in 1965 and is headquartered in Braunschweig, Germany.